Intracoronary ST segment evolution during primary coronary stenting predicts infarct zone recovery

Catheterization and Cardiovascular Interventions

Volumn 64, Issue 1, 2005, Pages 53-60

  Balian, Vruyr ^a   Galli, Michele ^b   Repetto, Sergio ^a   Luvini, Marcella ^a   Galdangelo, Francesco ^a   Castiglioni, Battistina ^a   Boscarini, Mauro ^a   Petrucci, Ettore ^c   Filippini, Giulia ^c   Marcassa, Claudio ^d  

^a OSPEDALE DI CIRCOLO   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c BUSTO ARSIZIO HOSPITAL   (Italy)

^d IRCCS   (Italy)

Author keywords

Angioplasty; Electrocardiography; Myocardial infarction; Stents

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; RECANALIZATION; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; STENTS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 19944426593     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20236     Document Type: Article

References (31)

1. Kandzari DE, Tcheng JE. Double negatives. Am Heart J 2003;145:9-12.
2. Van't Hof A, Liem A, de Boer M, Zijlstra F, for the Zwolle Myocardial Infarction Study. Clinical value of 12-lad electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997;350:615-619.
3. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 1999;99:1972-1977.
4. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the "no-reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
5. De Lemos J, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-1294.
6. Santoro GM, Valenti R, Buonamici P, Bolognese L, Cerisano G, Moschi G, Trapani M, Antoniucci D, Fazzini PF. Relation between ST segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 1998;82:932-937.
7. Fernandez AR, Sequiera RF, Chakko S, Correa LF, Marchena ES, Chahine RA, Francecour D, Myerburg RJ. ST segment tracking for rapid determination of patency of the infarct related artery in acute myocardial infarction. J Am Coll Cardiol 1995;26:675-683.
8. Somitsu Y, Nakamura M, Degawa T, Yamaguchi T. Prognostic value of slow resolution of ST segment elevation following successful direct percutaneous transluminal coronary angioplasty for recovery of the left ventricular function. Am J Cardiol 1997;80:406-410.
9. Pande AK, Meier B, Urban P, Moles V, Dorsaz PA, Favre J. Intracoronary electrocardiogram during coronary angioplasty. Am Heart J 1992;124:337-341.
10. Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation 1986;74:330-339.
11. TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
12. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-592.
13. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkowitz K, Bourdillon PDV, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-415.
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommandatation for quantitation of the LV by 2-D Echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
15. Schröder K, Wegscheider K, Zeymer U, Tebbe U, Schröder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 2001;358:1479-1486.
16. De Lemos JA, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Van der Werf F, Gibson CM, Braunwald E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy: Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. Am J Cardiol 2000;85:299-304.
17. Bolognese L, Antoniucci D, Rovai D, Buonamici P, Cerisano G, Santoro GM, Marini C, L'Abbate A, Fazzini PF. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996;28:1677-1683.
18. Dong J, Ndrepepa G, Schmitt C, Mehilli J, Schmieder S, Schwaiger M, Shomig A, Kastrati A. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation 2002;105:2946-2949.
19. Van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998;97:2302-2306.
20. Iwakura K, Ito H, Nishikawa N, Hiraoka K, Sugimoto K, Higashino Y, Masuyama T, Hori M, Fujii K, Minamino T. Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon. Am J Cardiol 1999;84:415-419.
21. Langer A, Krocoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Califf RM, Armstrong PW, for the GUSTO-I ECG Monitoring Substudy Group. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST segment monitoring substudy. J Am Coll Cardiol 1998;31:783-789.
22. Pucci PD, Antoniucci D, Boddi V, Bolognese L, Buonamici P, Cerisano G, Moschi G, Santini A, Trapani M, Fazzini PF. Rapid resolution of ST-segment elevation resolution predicts functional recovery in acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty. G Ital Cardiol 1998;28:554-563.
23. Gibson CM, Cannon CP, Daley WD, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E, for the TIMI 4 study group. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
24. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran G, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-597.
25. Marzilli M, Orsini E, Marracini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000;101:2154-2159.
26. Taniyama Y, Ito H, Uwakura K, Masuyama T, Hori M, Takiuchi S, Nishikawa N, Higashino Y, Fujii K, Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-1199.
27. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-660.
28. Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Pompa JJ, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 2003;145:42-46.
29. Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, Kastrati A, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 198;98:2695-2701.
30. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Maillard L, Pansieri M, Choussa R, Pinton P, for the ADMIRAL investigators. Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term follow-up: platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-1903.
31. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll J, Rutherford B, Lansky AJ, for the CADILLAC investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966.